DocGo Inc (DCGO)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $20.55M
Last updated: Nov 17, 2026 at 11:02 AM ET
DocGo Inc (DCGO) Financials: Revenue, Profit and Cash Flow
DocGo reported revenue of $322.20M for the fiscal year ended Dec 31, 2025, down 47.7% from the year before. That year, net income was -$196.37M with a net margin of -60.9%, operating cash flow was $34.45M and free cash flow was $29.91M. The quarter ended Sep 30, 2026 had revenue of $73.43M and net income of -$18.29M.
Revenue and Margins
The operating margin was -55.3% in the fiscal year ended Dec 2025, the lowest of the 7 years shown. Over the 6 years to Dec 2025, revenue grew from $48.30M, a compound annual rate of 37.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $322.20M | -47.7% | 30.7% | -55.3% | -60.9% |
| Dec 2024 | $616.56M | -1.2% | 34.6% | 4.7% | 2.2% |
| Dec 2023 | $624.29M | +41.7% | 31.3% | 2.4% | 1.6% |
| Dec 2022 | $440.52M | +38.2% | 35.1% | 5.0% | 7.0% |
| Dec 2021 | $318.72M | +238.7% | 34.4% | 4.8% | 6.0% |
| Dec 2020 | $94.09M | +94.8% | 33.3% | -15.7% | -15.7% |
| Dec 2019 | $48.30M | N/A | 27.3% | -43.0% | -41.8% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $322.20M | $616.56M | $624.29M | $440.52M | $318.72M | $94.09M | $48.30M |
| Cost of revenue | $223.44M | $402.98M | $428.91M | $285.79M | $208.97M | $62.74M | $35.11M |
| Gross profit | $98.76M | $213.57M | $195.38M | $154.72M | $109.75M | $31.35M | $13.19M |
| Research and development | $13.56M | $11.59M | $10.86M | $5.38M | $3.32M | $1.19M | $1.22M |
| Operating income | -$178.03M | $28.69M | $15.05M | $21.83M | $15.36M | -$14.76M | -$20.76M |
| Net income | -$196.37M | $13.36M | $10.05M | $30.74M | $19.18M | -$14.80M | -$20.21M |
| EBITDA | -$170.35M | $45.88M | $31.38M | $32.58M | $27.55M | -$8.92M | -$16.58M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $73.43M | $73.42M | $75.55M | $74.94M | $70.81M | $80.42M | $96.03M | $120.83M | $138.68M | $164.95M | $192.09M | $199.25M |
| Gross profit | $73.43M | $73.42M | $75.55M | -$148.50M | $70.81M | $80.42M | $96.03M | -$282.15M | $138.68M | $164.95M | $192.09M | -$98.16M |
| Operating income | -$17.28M | -$17.92M | -$18.71M | -$104.58M | -$41.98M | -$17.48M | -$14.00M | -$7.47M | $10.14M | $10.15M | $15.88M | $11.67M |
| Net income | -$18.29M | -$17.99M | -$16.70M | -$142.34M | -$29.66M | -$13.29M | -$11.08M | -$7.65M | $4.55M | $5.86M | $10.60M | $7.99M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $3.28M by $47.74M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Total assets | $217.10M | $455.62M | $490.45M | $393.28M | $309.60M | $100.17M | $100.96M |
| Current assets | $152.40M | $304.49M | $338.87M | $271.08M | $256.03M | $58.42M | $59.14M |
| Cash and equivalents | $51.02M | $89.24M | $59.29M | $157.34M | $175.54M | $32.42M | $47.74M |
| Total liabilities | $91.23M | $140.44M | $185.28M | $114.35M | $82.55M | $33.23M | $21.60M |
| Short-term debt | $3.09M | $34.99M | $25.03M | $664.91K | $626.33K | $664.36K | $3.67M |
| Long-term debt | $183.84K | $5.21K | $41.59K | $1.24M | $1.30M | $594.49K | $751.50K |
| Shareholder equity | $144.01M | $320.92M | $300.79M | $273.23M | $219.58M | $55.00M | $68.47M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $173.90M | $186.82M | $209.23M | $217.10M | $353.78M | $408.26M | $430.79M | $455.62M | $493.88M | $488.17M | $490.69M | $490.45M |
| Total liabilities | $94.92M | $91.04M | $98.02M | $91.23M | $93.12M | $120.53M | $128.87M | $140.44M | $168.98M | $170.18M | $175.61M | $185.28M |
| Cash and equivalents | $19.11M | $25.23M | $35.68M | $51.02M | $73.36M | $104.16M | $79.01M | $89.24M | $89.46M | $66.06M | $41.24M | $59.29M |
| Shareholder equity | $105.08M | $119.05M | $132.31M | $144.01M | $270.53M | $297.28M | $309.34M | $320.92M | $325.21M | $315.16M | $311.32M | $305.17M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 86.8% of operating cash flow. Dividends and share repurchases together came to 36.8% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $34.45M | $70.12M | -$64.49M | $28.87M | -$1.95M | -$10.65M | -$14.21M |
| Capital expenditures | $4.54M | $3.61M | $7.31M | $3.20M | $4.81M | $4.36M | $3.80M |
| Free cash flow | $29.91M | $66.50M | -$71.81M | $25.67M | -$6.76M | -$15.02M | -$18.01M |
| Dividends paid | $175.83K | $3.14M | $0 | $0 | $19.96M | N/A | N/A |
| Share repurchases | $10.83M | $13.76M | $0 | $3.75M | $0 | $0 | N/A |
| Investing cash flow | -$39.08M | -$10.65M | -$29.61M | -$38.45M | -$8.59M | -$6.04M | -$2.97M |
| Financing cash flow | -$50.82M | -$24.15M | $1.12M | -$6.18M | $155.21M | -$812.09K | $56.34M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.62M | -$9.24M | -$4.66M | -$10.47M | $1.66M | $34.04M | $9.22M | $12.72M | $31.15M | $36.89M | -$10.64M | -$6.19M |
| Capital expenditures | $2.16M | $320.83K | $430.31K | $1.50M | $2.95M | $1.14M | $1.03M | $724.80K | $902.16K | $1.03M | $951.70K | $2.95M |
| Free cash flow | -$5.78M | -$9.56M | -$5.09M | -$11.96M | -$1.29M | $32.90M | $8.19M | $11.99M | $30.25M | $35.85M | -$11.59M | -$9.14M |
Frequently Asked Questions About DCGO
What is DocGo's annual revenue?
DocGo reported revenue of $322.20M for the fiscal year ended Dec 31, 2025.
How fast is DocGo's revenue growing?
Revenue was down 47.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -9.9%.
Is DocGo profitable?
No. DocGo reported net income of -$196.37M for the fiscal year ended Dec 31, 2025, with a net margin of -60.9%.
How much free cash flow does DCGO generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $34.45M minus capital expenditures of $4.54M produced free cash flow of $29.91M.
How much debt does DocGo have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $183.84K, short-term debt of $3.09M and cash and equivalents of $51.02M.
DCGO pages: Overview, Earnings, Forecast, Financials, Competitors